Barr Meaghan L, Chiu Harvey K, Li Ning, Yeh Michael W, Rhee Connie M, Casillas Jacqueline, Iskander Paul J, Leung Angela M
University of California Los Angeles (UCLA) David Geffen School of Medicine (M.L.B.), Los Angeles 90073, California; Division of Pediatric Endocrinology (H.K.C.), Department of Pediatrics, UCLA David Geffen School of Medicine, Los Angeles, California 90073; Department of Biomathematics (N.L.), UCLA David Geffen School of Medicine, Los Angeles, California 90073; Section of Endocrine Surgery (M.W.Y.), Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California 90073; Division of Nephrology and Hypertension (C.M.R.), University of California Irvine School of Medicine, Irvine, California 92697; Division of Pediatric Hematology and Oncology (J.C.), Department of Pediatrics, UCLA David Geffen School of Medicine, Los Angeles, California 90073; Department of Radiology (P.J.I.), UCLA David Geffen School of Medicine, Los Angeles, California 90073; Division of Endocrinology (A.M.L.), Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, California 90073; and Division of Endocrinology (A.M.L.), Veterans' Affairs Greater Los Angeles Healthcare System, Los Angeles, California 90073.
J Clin Endocrinol Metab. 2016 Jun;101(6):2366-70. doi: 10.1210/jc.2016-1330. Epub 2016 Mar 28.
Iodinated contrast media (ICM) is routinely used in imaging studies and contains several 100-fold the recommended daily allowance of iodine.
To determine whether children exposed to ICM have a higher risk of iodine-induced thyroid dysfunction.
This was a single-institution case-control study, examining patients with incident thyroid dysfunction aged less than 18 years from 2001 to 2015. Cases were matched 1:1 to euthyroid controls by age, sex, and race.
This was a single-institution case-control study occurring at tertiary care center.
Cases were defined as those with thyroid dysfunction (by International Classification of Diseases, Ninth Revision diagnosis codes and/or 2 consecutive abnormal serum TSH values <6 mo apart). We analyzed 870 cases matched to 870 controls (64% female, 51% White).
Using conditional logistic regression, the association between ICM exposure and the primary outcome, thyroid dysfunction, occurring within 2 years of exposure was assessed.
Sixty-nine patients received ICM, including 53 (6%) among cases and 16 (2%) among controls. The risk of incident hypothyroidism was significantly higher after ICM exposure (odds ratio 2.60; 95% confidence interval, 1.43-4.72; P < .01). The median interval between exposure and onset of hypothyroidism was 10.8 months (interquartile range, 6.6-17.9). In hypothyroid cases, the median serum TSH concentration was 6.5 mIU/L (interquartile range, 5.8-9.6).
ICM exposure increases the risk of incident hypothyroidism in pediatric patients. Children receiving ICM should be monitored for iodine-induced thyroid dysfunction, particularly during the first year after exposure.
碘化造影剂(ICM)常用于影像学检查,其含碘量是每日推荐摄入量的数百倍。
确定接触ICM的儿童发生碘诱导甲状腺功能障碍的风险是否更高。
这是一项单机构病例对照研究,研究对象为2001年至2015年年龄小于18岁的新发甲状腺功能障碍患者。病例与甲状腺功能正常的对照按年龄、性别和种族进行1:1匹配。
这是一项在三级医疗中心进行的单机构病例对照研究。
病例定义为患有甲状腺功能障碍的患者(根据国际疾病分类第九版诊断编码和/或相隔<6个月的连续2次异常血清促甲状腺激素值)。我们分析了870例病例和870例对照(64%为女性,51%为白人)。
采用条件逻辑回归分析,评估ICM暴露与暴露后2年内发生的主要结局即甲状腺功能障碍之间的关联。
69例患者接受了ICM,其中病例组53例(6%),对照组16例(2%)。ICM暴露后发生甲状腺功能减退的风险显著更高(比值比2.60;95%置信区间,1.43 - 4.72;P <.01)。暴露与甲状腺功能减退发作之间的中位间隔时间为10.8个月(四分位间距,6.6 - 17.9)。在甲状腺功能减退病例中,血清促甲状腺激素浓度中位数为6.5 mIU/L(四分位间距,5.8 - 9.6)。
ICM暴露增加了儿科患者发生甲状腺功能减退的风险。接受ICM的儿童应监测碘诱导的甲状腺功能障碍,尤其是在暴露后的第一年。